<?xml version="1.0" encoding="UTF-8"?>
<SAMPLE_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <SAMPLE alias="nthy puro" accession="SRS4538386">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4538386</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN11255658</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Nthy-ori 3-1 transduced by lentivitus containing LeGo-iPuro2plasmid</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_LINKS>
      <SAMPLE_LINK>
        <XREF_LINK>
          <DB>bioproject</DB>
          <ID>529086</ID>
          <LABEL>PRJNA529086</LABEL>
        </XREF_LINK>
      </SAMPLE_LINK>
    </SAMPLE_LINKS>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>Transformed cell line, normal human primary thyroid follicular epithelial cells were transfected with a plasmid containing an origin-defective SV40 genome (SV-ori) to immortalise them.</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biomaterial_provider</TAG>
        <VALUE>Nthy-ori 3-1 Cell Line human was provided by Sigma-Aldrich, modification of the line were performed in Kuprash lab, Engelhardt Institute of molecular biology RAS, 119991, Moscow</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>tissue</TAG>
        <VALUE>human thyroid (follicular epithelial)</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>Nthy-ori 3-1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>treatment</TAG>
        <VALUE>+sc</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>BioSampleModel</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="v600e si" accession="SRS4538388">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4538388</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN11255656</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Nthy-ori 3-1 transduced by lentivitus containing LeGo-iPuro2-BRAF V600E plasmid and with si-mediated knockdown of PTPPN11 gene</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_LINKS>
      <SAMPLE_LINK>
        <XREF_LINK>
          <DB>bioproject</DB>
          <ID>529086</ID>
          <LABEL>PRJNA529086</LABEL>
        </XREF_LINK>
      </SAMPLE_LINK>
    </SAMPLE_LINKS>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>Transformed cell line, normal human primary thyroid follicular epithelial cells were transfected with a plasmid containing an origin-defective SV40 genome (SV-ori) to immortalise them.</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biomaterial_provider</TAG>
        <VALUE>Nthy-ori 3-1 Cell Line human was provided by Sigma-Aldrich, modification of the line were performed in Kuprash lab, Engelhardt Institute of molecular biology RAS, 119991, Moscow</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>tissue</TAG>
        <VALUE>human thyroid (follicular epithelial)</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>Nthy-ori 3-1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_subtype</TAG>
        <VALUE>BRAFV600E</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>treatment</TAG>
        <VALUE>+si PTPN11</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>BioSampleModel</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="v600e sc" accession="SRS4538390">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4538390</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN11255654</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Nthy-ori 3-1 transduced by lentivitus containing LeGo-iPuro2-BRAF V600E plasmid</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_LINKS>
      <SAMPLE_LINK>
        <XREF_LINK>
          <DB>bioproject</DB>
          <ID>529086</ID>
          <LABEL>PRJNA529086</LABEL>
        </XREF_LINK>
      </SAMPLE_LINK>
    </SAMPLE_LINKS>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>Transformed cell line, normal human primary thyroid follicular epithelial cells were transfected with a plasmid containing an origin-defective SV40 genome (SV-ori) to immortalise them.</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biomaterial_provider</TAG>
        <VALUE>Nthy-ori 3-1 Cell Line human was provided by Sigma-Aldrich, modification of the line were performed in Kuprash lab, Engelhardt Institute of molecular biology RAS, 119991, Moscow</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>tissue</TAG>
        <VALUE>human thyroid (follicular epithelial)</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>Nthy-ori 3-1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_subtype</TAG>
        <VALUE>BRAFV600E</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>treatment</TAG>
        <VALUE>+sc</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>BioSampleModel</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="nthy si" accession="SRS4538384">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4538384</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN11255660</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Nthy-ori 3-1 with si-mediated knockdown of PTPPN11 gene</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_LINKS>
      <SAMPLE_LINK>
        <XREF_LINK>
          <DB>bioproject</DB>
          <ID>529086</ID>
          <LABEL>PRJNA529086</LABEL>
        </XREF_LINK>
      </SAMPLE_LINK>
    </SAMPLE_LINKS>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>Transformed cell line, normal human primary thyroid follicular epithelial cells were transfected with a plasmid containing an origin-defective SV40 genome (SV-ori) to immortalise them.</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biomaterial_provider</TAG>
        <VALUE>Nthy-ori 3-1 Cell Line human was provided by Sigma-Aldrich, modification of the line were performed in Kuprash lab, Engelhardt Institute of molecular biology RAS, 119991, Moscow</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>tissue</TAG>
        <VALUE>human thyroid (follicular epithelial)</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>Nthy-ori 3-1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>treatment</TAG>
        <VALUE>+si PTPN11</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>BioSampleModel</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="nthy si+vem" accession="SRS4538385">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4538385</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN11255661</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Nthy-ori 3-1 treated with vemurafenib and with si-mediated knockdown of PTPPN11 gene</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_LINKS>
      <SAMPLE_LINK>
        <XREF_LINK>
          <DB>bioproject</DB>
          <ID>529086</ID>
          <LABEL>PRJNA529086</LABEL>
        </XREF_LINK>
      </SAMPLE_LINK>
    </SAMPLE_LINKS>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>Transformed cell line, normal human primary thyroid follicular epithelial cells were transfected with a plasmid containing an origin-defective SV40 genome (SV-ori) to immortalise them.</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biomaterial_provider</TAG>
        <VALUE>Nthy-ori 3-1 Cell Line human was provided by Sigma-Aldrich, modification of the line were performed in Kuprash lab, Engelhardt Institute of molecular biology RAS, 119991, Moscow</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>tissue</TAG>
        <VALUE>human thyroid (follicular epithelial)</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>Nthy-ori 3-1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>treatment</TAG>
        <VALUE>+si PTPN11, +vemurafenib</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>BioSampleModel</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="nthy sc+vem" accession="SRS4538387">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4538387</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN11255659</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Nthy-ori 3-1 treated by vemurafenib</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_LINKS>
      <SAMPLE_LINK>
        <XREF_LINK>
          <DB>bioproject</DB>
          <ID>529086</ID>
          <LABEL>PRJNA529086</LABEL>
        </XREF_LINK>
      </SAMPLE_LINK>
    </SAMPLE_LINKS>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>Transformed cell line, normal human primary thyroid follicular epithelial cells were transfected with a plasmid containing an origin-defective SV40 genome (SV-ori) to immortalise them.</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biomaterial_provider</TAG>
        <VALUE>Nthy-ori 3-1 Cell Line human was provided by Sigma-Aldrich, modification of the line were performed in Kuprash lab, Engelhardt Institute of molecular biology RAS, 119991, Moscow</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>tissue</TAG>
        <VALUE>human thyroid (follicular epithelial)</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>Nthy-ori 3-1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>treatment</TAG>
        <VALUE>+sc, +vemurafenib</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>BioSampleModel</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="v600e si+vem" accession="SRS4538389">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4538389</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN11255657</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Nthy-ori 3-1 transduced by lentivitus containing LeGo-iPuro2-BRAF V600E plasmid treated with vemurafenib and with si-mediated knockdown of PTPPN11 gene</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_LINKS>
      <SAMPLE_LINK>
        <XREF_LINK>
          <DB>bioproject</DB>
          <ID>529086</ID>
          <LABEL>PRJNA529086</LABEL>
        </XREF_LINK>
      </SAMPLE_LINK>
    </SAMPLE_LINKS>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>Transformed cell line, normal human primary thyroid follicular epithelial cells were transfected with a plasmid containing an origin-defective SV40 genome (SV-ori) to immortalise them.</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biomaterial_provider</TAG>
        <VALUE>Nthy-ori 3-1 Cell Line human was provided by Sigma-Aldrich, modification of the line were performed in Kuprash lab, Engelhardt Institute of molecular biology RAS, 119991, Moscow</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>tissue</TAG>
        <VALUE>human thyroid (follicular epithelial)</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>Nthy-ori 3-1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_subtype</TAG>
        <VALUE>BRAFV600E</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>treatment</TAG>
        <VALUE>+si PTPN11, +vemurafenib</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>BioSampleModel</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
  <SAMPLE alias="v600e sc+vem" accession="SRS4538391">
    <IDENTIFIERS>
      <PRIMARY_ID>SRS4538391</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioSample">SAMN11255655</EXTERNAL_ID>
    </IDENTIFIERS>
    <TITLE>Nthy-ori 3-1 transduced by lentivitus containing LeGo-iPuro2-BRAF V600E plasmid treated by vemurafenib</TITLE>
    <SAMPLE_NAME>
      <TAXON_ID>9606</TAXON_ID>
      <SCIENTIFIC_NAME>Homo sapiens</SCIENTIFIC_NAME>
    </SAMPLE_NAME>
    <SAMPLE_LINKS>
      <SAMPLE_LINK>
        <XREF_LINK>
          <DB>bioproject</DB>
          <ID>529086</ID>
          <LABEL>PRJNA529086</LABEL>
        </XREF_LINK>
      </SAMPLE_LINK>
    </SAMPLE_LINKS>
    <SAMPLE_ATTRIBUTES>
      <SAMPLE_ATTRIBUTE>
        <TAG>isolate</TAG>
        <VALUE>Transformed cell line, normal human primary thyroid follicular epithelial cells were transfected with a plasmid containing an origin-defective SV40 genome (SV-ori) to immortalise them.</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>age</TAG>
        <VALUE>35</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>biomaterial_provider</TAG>
        <VALUE>Nthy-ori 3-1 Cell Line human was provided by Sigma-Aldrich, modification of the line were performed in Kuprash lab, Engelhardt Institute of molecular biology RAS, 119991, Moscow</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>sex</TAG>
        <VALUE>female</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>tissue</TAG>
        <VALUE>human thyroid (follicular epithelial)</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_line</TAG>
        <VALUE>Nthy-ori 3-1</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>cell_subtype</TAG>
        <VALUE>BRAFV600E</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>treatment</TAG>
        <VALUE>+sc, +vemurafenib</VALUE>
      </SAMPLE_ATTRIBUTE>
      <SAMPLE_ATTRIBUTE>
        <TAG>BioSampleModel</TAG>
        <VALUE>Human</VALUE>
      </SAMPLE_ATTRIBUTE>
    </SAMPLE_ATTRIBUTES>
  </SAMPLE>
</SAMPLE_SET>
